NCT05899751 2024-05-10
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
Unknown
Clinical Trials
5 trialsNCT00634504 2022-06-06
LVPK
BTG International Inc.
Phase 1 Completed
NCT01305655 2018-09-28
NOPHOCPG2
Nordic Society for Pediatric Hematology and Oncology
Phase 3 Completed
NCT00481559 2014-01-17
Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
BTG International Inc.
Approved for marketing
NCT00424645 2012-12-06
Voraxaze for Delayed Methotrexate Clearance
M.D. Anderson Cancer Center
Phase 1/2 Terminated